The statistic displays the domestic shipment volume of blood derivatives in Japan in 2016, broken down by agent. That year, the shipment volume of human serum albumin (25%50ml) amounted to approximately 1.2 million vials, followed by human serum albumin (5%250ml) with about 665 thousand vials.
Domestic shipment volume of blood derivatives in Japan in 2016, by agent (in 1,000 vials)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Production volume of blood derivatives Japan 2016, by agent
- Premium Statistic Drug production value of cardiovascular agents Japan 2021, by category
- Basic Statistic Total U.S. volume of immunoglobulin 2014-2019
- Premium Statistic Drug production value share of digestive organ agents Japan 2018, by category
- Basic Statistic Purchases in pharmaceutical manufacturing in the UK 2008-2021, by subdivision
- Basic Statistic Pharmaceuticals manufacturing expenditure in the UK 2008-2021, by subdivision
- Basic Statistic Enterprises in manufacture of pharma products and preparations UK 2008-2021
- Basic Statistic Revenue of pharmaceutical products manufacturing in the UK 2008-2021
- Basic Statistic Pharmaceuticals manufacture: purchases of goods, materials and services UK 2008-2021
- Basic Statistic U.S. number of venture capital deals for psychiatry companies 2006-2023
About the region
10
- Premium Statistic Production value of antidiarrheals intestinal regulators Japan 2021, by agent
- Premium Statistic Production volume antidiarrheals intestinal regulators Japan 2021, by agent
- Premium Statistic Number of medical clinics Japan 2011-2020
- Premium Statistic Number of actively employed pharmacists in Japan 2002-2020
- Premium Statistic Number of pharmacists per 100,000 inhabitants in Japan 2002-2020
- Premium Statistic Chugai Pharmaceutical's R&D expenditure 2013-2022
- Premium Statistic Number of physicians in medical care in Japan 2002-2020
- Premium Statistic Sawai Pharmaceutical's total assets FY 2011-2020
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Premium Statistic Number of medical drug manufacturing plants Japan 2018, by employee size
Selected statistics
5
- Basic Statistic Merck & Co total assets 2009-2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
Other regions
10
- Premium Statistic Share of global immunoglobulin therapies market 2017, by country
- Premium Statistic Italy: expenditure on non-reimbursable medicines 2021, by region
- Basic Statistic Leading dispensed antisecretory drugs in England 2022, by item number
- Premium Statistic ATMP registered trials number globally 1999-2015
- Premium Statistic Physicians that received opioid-manufacturer payments in New York 2013-2015
- Premium Statistic Key sources of information on medicines and supplements in Poland 2019
- Premium Statistic Share of pharma offline ad spend in Russia 2019, by category
- Premium Statistic Sales revenue Celltrion 2013-2022
- Basic Statistic Net export value of pharmaceuticals from Sweden 2012-2022
- Premium Statistic Export value medical equipment Indonesia 2019-2022
Related statistics
10
- Premium Statistic Major drug manufacturers Japan 2017, by number of products
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Market size osteoporosis drug market Japan 2014-2024
- Premium Statistic Astellas Pharma's net profit FY 2013-2022
- Premium Statistic Astellas Pharma's total assets FY 2013-2022
- Premium Statistic Astellas Pharma's revenue FY 2022, by region
- Premium Statistic Astellas Pharma's employee numbers FY 2014-2022
- Basic Statistic Astellas Pharma's revenue FY 2013-2022
Further related statistics
10
- Pfizer's ad spending 2008-2022
- Net earnings of UnitedHealth Group 2007-2022
- Overweight prevalence in England 2000-2021, by gender
- Medicaid long-term care services expenditures by type of service 1990-21
- New cases of mumps in the U.S. 1970-2019
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1950-2019
- Deaths by prostate cancer in the U.S. 1950-2019
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2008-2022
- Net earnings of UnitedHealth Group 2007-2022
- Overweight prevalence in England 2000-2021, by gender
- Medicaid long-term care services expenditures by type of service 1990-21
- New cases of mumps in the U.S. 1970-2019
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1950-2019
- Deaths by prostate cancer in the U.S. 1950-2019
MHLW (Japan). (September 20, 2018). Domestic shipment volume of blood derivatives in Japan in 2016, by agent (in 1,000 vials) [Graph]. In Statista. Retrieved December 02, 2023, from https://www.statista.com/statistics/756899/japan-domestic-shipment-volume-blood-derivatives-by-agent/
MHLW (Japan). "Domestic shipment volume of blood derivatives in Japan in 2016, by agent (in 1,000 vials)." Chart. September 20, 2018. Statista. Accessed December 02, 2023. https://www.statista.com/statistics/756899/japan-domestic-shipment-volume-blood-derivatives-by-agent/
MHLW (Japan). (2018). Domestic shipment volume of blood derivatives in Japan in 2016, by agent (in 1,000 vials). Statista. Statista Inc.. Accessed: December 02, 2023. https://www.statista.com/statistics/756899/japan-domestic-shipment-volume-blood-derivatives-by-agent/
MHLW (Japan). "Domestic Shipment Volume of Blood Derivatives in Japan in 2016, by Agent (in 1,000 Vials)." Statista, Statista Inc., 20 Sep 2018, https://www.statista.com/statistics/756899/japan-domestic-shipment-volume-blood-derivatives-by-agent/
MHLW (Japan), Domestic shipment volume of blood derivatives in Japan in 2016, by agent (in 1,000 vials) Statista, https://www.statista.com/statistics/756899/japan-domestic-shipment-volume-blood-derivatives-by-agent/ (last visited December 02, 2023)
Domestic shipment volume of blood derivatives in Japan in 2016, by agent (in 1,000 vials) [Graph], MHLW (Japan), September 20, 2018. [Online]. Available: https://www.statista.com/statistics/756899/japan-domestic-shipment-volume-blood-derivatives-by-agent/